Mobile Menu

Genomics week in brief: Week ending 30th October

Take a look at some of the latest genomics news and research from the past week in your latest Genomics Week in Brief.

Top stories from the past week

  • Researchers have identified a new skin cell that may underlie inflammatory skin disease. (Nakamizo et al, 2021)
  • New research has suggested that there is a common genetic basis underlying a person’s moral attitudes toward sex and recreational drug use. (Karinen et al, 2021)
  • A preclinical study has shown that blocking the Bach1 protein can slow down the deterioration of brain cells in Parkinson’s disease. (Greseth, 2021)
  • New research suggests that genetic liability to a variety of mental health conditions may affect where an individual chooses to live. (Maxwell et al, 2021)
  • A new study has identified a gene, Cdc42, that is crucial to sperm cell production. (Heinrich et al, 2021)
  • Researchers have described how cancer can leverage evolution and basic cellular functions to promote immune dysfunction. (Xian et al, 2021)
  • Scientists have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal. (Sánchez-López et al, 2021)
  • A genome-wide screening technique has revealed mechanisms that drive human embryonic stem cell behaviour. (Naxerova et al, 2021)
  • A study has reported a new antibiotic that binds to the ribosome of bacterial cells. This antibiotic is able to act against drug-resistant bacteria. (Mitcheltree et al, 2021)
  • By examining more than 800,000 people, researchers have identified genes that play a role in osteoarthritis. (Boer et al, 2021)
  • A team of scientists has developed a new drug-like molecule that can counteract the effects of mutated epigenetic regulators, which are known to drive certain cancer types. (Suh et al, 2021)

In other news

  • As part of the UK Government’s increased funding for health-related R&D, Genomics England is set to receive funding to support initiatives such as the national pilot of using genome sequencing in 100,000 newborns to detect rare diseases. (Bloomberg, 2021)
  • The NIH, FDA, 10 pharma companies and 5 non-profit organisations have partnered to accelerate the development of gene therapies for rare diseases. (NIH, 2021)

Image credit: canva

More on these topics

Cancer / Genomics / Mental Health / Week in brief